Second Scight, led by Dr. Sébastien Wieckowski, is a prominent brand offering a range of specialized scientific services. With over 15 years of experience in immuno-oncology and cancer vaccine development, Dr. Wieckowski brings a wealth of expertise to the biotechnology sector. His services include the analysis of experimental data, RNA-Seq, vaccine design, and more. Dr. Wieckowski's extensive background in immunology techniques, data analysis, and bioinformatics ensures high-quality deliverables, such as biostatistical reports and scientific articles.

Additionally, Second Scight provides services like flow cytometry, nonclinical regulatory support, and bioinformatics due diligence. Dr. Wieckowski's professional journey includes roles as a Director in nonclinical development at Worg Pharmaceuticals and as a Principal Scientist at VAXIMM GmbH. With a strong emphasis on technical leadership and innovation, Second Scight is your go-to brand for comprehensive scientific insights and analysis.